Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?

Isamu Okamoto; Moritaka Suga

doi:10.2169/internalmedicine.42.926

Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?

Isamu Okamoto, Moritaka Suga

Respiratory Medicine

Research output: Contribution to journal › Editorial › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	926-927
Number of pages	2
Journal	Internal Medicine
Volume	42
Issue number	10
DOIs	https://doi.org/10.2169/internalmedicine.42.926
Publication status	Published - Oct 2003

All Science Journal Classification (ASJC) codes

Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2169/internalmedicine.42.926

Cite this

@article{6b4fc2b9ffc2413aaea1f0c5a3022fac,

title = "Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?",

author = "Isamu Okamoto and Moritaka Suga",

year = "2003",

month = oct,

doi = "10.2169/internalmedicine.42.926",

language = "English",

volume = "42",

pages = "926--927",

journal = "Internal Medicine",

issn = "0918-2918",